Search Results 2181-2190 of 18841 for Relapse

  1. Publications - Sebastian S. Lopez Chiriboga, M.D. - Mayo Clinic

    Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

  2. Multiple myeloma - Symptoms and causes - Mayo Clinic

    mSMART Mayo stratification for myeloma and risk-adapted therapy: Relapsed myeloma. mSMART. https://www.msmart.org/mm-treatment-guidelines. Accessed March 29 ...

  3. Parkinson's Blood Test May Reveal Disease Progression - Mayo Clinic News Network

    Journalists: sound bites with Dr. Mielke are available in the downloads. Root Cause of Multiple Myeloma Relapse Revealed · Caring Canines Bring ...

  4. Mayo Clinic Announces Four Performances in October for the Rosemary and Meredith Willson Harmony for Mayo Program

    Research Team Uncovers Root Cause Of Multiple Myeloma Relapse · Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics Center. Related Articles. Golf ...

  5. Mayo Clinic Minute: Some sexually transmitted infections reach record highs

    Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma. Related Articles. Mayo Clinic Minute: Treating severe headaches caused by nerve ...

  6. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics Center

    Root Cause of Multiple Myeloma Relapse Revealed. Related Articles. Mayo Clinic experimental dual-drug nanotherapy crosses the blood-brain barrier and improved ...

  7. A Study Of 177Lu-FAP-2286 In Advanced Solid Tumors - Mayo Clinic

    ... relapsed NSCLC. Participants in both Phase 1 and 2 will be selected for treatment with \[177Lu\]Lu FAP 2286 based on \[68Ga\]Ga FAP 2286 imaging for ...

  8. Tuesday Tips: What to know about the ketogenic diet for epilepsy

    Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma · In the Loop: Adult stem cells as treatment of the future. Related Articles. Mayo ...

  9. A Study to Evaluate Adjuvant Ado-Trastuzumab Emtansine (T-DM1) in HER2 Positive Breast Cancer - Mayo Clinic

    Concurrent second malignancy or past malignancy with >30% estimated risk of relapse in next 5 years. EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in ...

  10. Pioneering change: The inception and potential of Mayo Clinic's Nursing Research Scholars

    Mayo Clinic researchers link CAR-T cell aging to cancer relapse. Related Articles. New Mayo Clinic technique identifies proteins that trigger immune responses ...